The White House took a big leap forward on Monday to support research into the medical components of cannabis, lifting a much-abused bureaucratic need that for a long time suppressed scientific investigations.By getting rid of the Public Health Service review requirement, the Office of National Drug Control Policy, also identified as the drug czar’s office, will help provide research into marijuana. A bipartisan group of lawmakers had made attempts for the requirement to be lifted.The requirement for a while now has outgrown today’s marijuana politics. Even the competition of legalization has called for it to be lifted. While HuffPost’s Matt Ferner documented earlier: Today, cannabis research that is not financially supported by the government must go through a Public Health Service review– a system established back in 1999 by the federal government after a 1998 Institute of Medicine report illustrated the need for more scientific investigation into the medical value of cannabis. It is a process that no other substance identified by the government as Schedule 1 is subject to and one that researchers and lawmakers alike have criticized. Under the Controlled Substance Act, America has five categories for drugs and what they are made from. Drug czar spokesman Mario Moreno Zepeda stated,“The Obama Administration has actively supported scientific research on whether marijuana or its components can be safe and effective medicine. Eliminating the Public Health Service review should help facilitate additional research to advance our understanding of both the adverse effects and potential therapeutic uses for marijuana or its components.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
